• Title of article

    p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2

  • Author/Authors

    Isabel Chu، نويسنده , , Jun Sun، نويسنده , , Angel Arnaout، نويسنده , , Harriette Kahn، نويسنده , , Wedad Hanna، نويسنده , , Steven Narod، نويسنده , , Ping Sun، نويسنده , , Cheng-Keat Tan، نويسنده , , Ludger Hengst، نويسنده , , Joyce Slingerland، نويسنده ,

  • Issue Information
    هفته نامه با شماره پیاپی سال 2007
  • Pages
    14
  • From page
    281
  • To page
    294
  • Abstract
    The kinase inhibitor p27Kip1 regulates the G1 cell cycle phase. Here, we present data indicating that the oncogenic kinase Src regulates p27 stability through phosphorylation of p27 at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs the Cdk2 inhibitory action of p27 and reduces its steady-state binding to cyclin E-Cdk2 to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show reduced p27 and observe a correlation between Src activation and reduced nuclear p27 in 482 primary human breast cancers. Importantly, we report that in tamoxifen-resistant breast cancer cell lines, Src inhibition can increase p27 levels and restore tamoxifen sensitivity. These data provide a new rationale for Src inhibitors in cancer therapy.
  • Journal title
    CELL
  • Serial Year
    2007
  • Journal title
    CELL
  • Record number

    1018507